Showing results (1311-1320 of 5,275) with videos related to
Sort By:
Pageof 528
Oncology|September 9, 2026
Effects of amputation versus limb salvage surgery on the prognosis of primary extremity chondrosarcoma: Evidence from the Surveillance, Epidemiology, and End Results databaseHsin-Chang Chen, Yu-Cheng Lo, Ya-Ling Lee, et al.Oncology|September 22, 2026
Impact of Clinicopathologic Factors on Breast Cancer Diagnosed in PregnancyMalcolm Su, Diti Patel, Samira Syed, et al.Oncology|October 6, 2026
ErratumOncology|October 7, 2026
Stage-specific quality of life and tolerability of CDK4/6 inhibitors in HR-positive/HER2-negative breast cancer: a narrative reviewLuca Scafuri, Carlo Buonerba, Vincenzo Marotta, et al.Oncology|October 19, 2026
Hepatocellular carcinoma screening in a tertiary hospital. What are we missing?Francisco Capinha, Inês Coelho Rodrigues, Miguel Moura, et al.Oncology|October 20, 2026
Evaluating the Automated Extraction of Radiation Oncology Trial Data at Scale from the ClinicalTrials.gov Database Using a Large Language ModelFabio Dennstaedt, Lena Kretzschmar, Nikola Cihoric, et al.Oncology|January 1, 1975
Inhibition by 2,4-dinitrophenol of 9,10-dimethyl-1,2-benzanthracene carcinogenesis in the hamster cheek pouchI S Levij, D RubinOncology|January 1, 1992
A phase III comparison of etoposide/cisplatin with or without added ifosfamide in small-cell lung cancerH Miyamoto, T Nakabayashi, H Isobe, et al.Oncology|January 1, 1992
Randomized phase II trial of high-dose 4'-epi-doxorubicin + cyclophosphamide versus high-dose 4'-epi-doxorubicin + cisplatin in previously untreated patients with extensive small cell lung cancerE Kánitz, K Kolaric, J Jassem, et al.Oncology|December 15, 2010
High plasma TIMP-1 and serum CEA levels during combination chemotherapy for metastatic colorectal cancer are significantly associated with poor outcomeBahir Aldulaymi, Per Byström, Ake Berglund, et al.Pageof 528